Olga Potapova Exhibits Excellence in Medical Diagnostics
Olga Potapova developed prenatal diagnostic tests for such diseases as cystic fibrosis

SOUTH SAN FRANCISCO, CA, May 24, 2011 /24-7PressRelease/ -- Olga Potapova, President and Chief Executive Officer of Cureline, Inc., has been recognized by Cambridge Who's Who for demonstrating dedication, leadership and excellence in medical diagnostics.

Dr. Potapova has accrued expertise in translational oncology research and biotechnology throughout her 20 years of professional experience. As a president and CEO, she leads Cureline group of companies working in the area of translational medicine research and laboratory services, including human tissue biorepository with an emphasis on custom tissue procurement, a clinical research consulting group and a biopathology laboratory. With oncology as a primary focal point her research team expands its focus of study each year. Dr. Potapova is responsible for supervising staff, as well as overseeing scientific interaction, account management and strategic development. Additionally, she maintains a network of alliances with international organizations to process human specimens worldwide. She have served in this capacity for the past seven years.

In 1994, Dr. Potapova earned a Ph.D. in biochemistry and human genetics. She utilized her education to develop targeted therapies and human prenatal diagnostic tests for such diseases as cystic fibrosis. Her professional affiliations include the AACR and ISBER. For her achievements, Dr. Potapova was honored by NATO with a fellowship award. She hopes to aid her company's expansion and growth in the future.

For more information about Cureline, Inc., visit http://www.cureline.com.

Press Release Contact Information:

Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x4266
Website: Visit Our Website